Wolverine Trading, LLC Adamis Pharmaceuticals Corp Put Options Transaction History

Wolverine Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 06, 2021	SELL	$0.66 - $1.23 $15,444 - $28,782	-23,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$0.54 - $1.79 $12,636 - $41,886	23,400 New	23,400 $22,000
Q3 2019 Nov 14, 2019	SELL	$0.7 - $1.46 $7,699 - $16,060	-11,000 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$1.26 - $2.23 $6,174 - $10,927	-4,900 Reduced 30.82%	11,000 $14,000
Q1 2019 May 15, 2019	BUY	$2.02 - $3.22 $4,444 - $7,084	2,200 Added 16.06%	15,900 $34,000
Q4 2018 Feb 14, 2019	BUY	$2.1 - $3.21 $3,990 - $6,099	1,900 Added 16.1%	13,700 $29,000
Q3 2018 Nov 14, 2018	SELL	$2.25 - $4.8 $22,050 - $47,040	-9,800 Reduced 45.37%	11,800 $41,000
Q1 2018 May 15, 2018	BUY	$2.55 - $4.85 $26,774 - $50,924	10,500 Added 94.59%	21,600 $76,000
Q4 2017 Feb 14, 2018	SELL	$3.5 - $5.65 $27,650 - $44,635	-7,900 Reduced 41.58%	11,100 $49,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $5.65 $85,500 - $107,350	19,000	19,000 $99,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.